Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$8.04 -0.15 | -1.83%
09/22/14 - 10:06 AM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
SUPNSector Avg.S&P 500
n/a028.91
Price Performance History (% change):
3 Mo1 Yr3 Yr
-22.553219.2140
GROWTH12 Mo3 YrCAGR
Revenue712.1-0.11-0.04
Net Income1.40
EPS0n/a
Earnings for SUPN:
EBITDA-61.00
REVENUE12.02M
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.45 $-0.15 $0.10 $0.27
Number of Analysts 3 3 3 4
High Estimate $0.52 $-0.09 $0.27 $0.43
Low Estimate $0.41 $-0.19 $-0.03 $0.07
Prior Year $-0.65 $-0.39 $-2.18 $0.10
Growth Rate (Year over Year) 169.74% 61.54% 104.59% 167.50%

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter